Werewolf Therapeutics(HOWL.US)

Last Updated 19:00:00 ET
longbridge loading

Werewolf Reports Q1 Loss Of $13 Mln, Highlights Asset Purchase Agreement With Jazz

nasdaq·
US
HOWL
+2.24%
US
JAZZ
+0.66%
US
IBBQ
+2.43%
nasdaq·
US
HOWL
+2.24%
US
JAZZ
+0.66%
US
IBBQ
+2.43%

Werewolf Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
HOWL
+2.24%
Earnings Watch·
US
HOWL
+2.24%

Werewolf Therapeutics | 8-K: FY2026 Q1 EPS Beats Estimate at USD -0.28

Earnings Watch·
US
HOWL
+2.24%
Earnings Watch·
US
HOWL
+2.24%

Pre-market hot trades in US stocks: Wingstop pre-market down 8.65%; Werewolf Therapeutics pre-market up 7.97%

Price Alert·
US
WING
+1.05%
US
HOWL
+2.24%
Price Alert·
US
WING
+1.05%
US
HOWL
+2.24%

Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price

Tip Ranks·
US
SBIO
+3.75%
US
LABU
+11.76%
US
ARKG
+5.05%
Tip Ranks·
US
SBIO
+3.75%
US
LABU
+11.76%
US
ARKG
+5.05%

Earnings Scheduled For March 27, 2026

benzinga_article·
US
LGN
+2.59%
US
SBIO
+3.75%
US
BBH
+0.96%
benzinga_article·
US
LGN
+2.59%
US
SBIO
+3.75%
US
BBH
+0.96%

Werewolf Therapeutics | 8-K: FY2025 Q4 Revenue: USD 0

Earnings Watch·
US
HOWL
+2.24%
Earnings Watch·
US
HOWL
+2.24%
© 2026 Longbridge｜Disclaimer